Abbott (ABT) Tops Q3 EPS by 20c, Beats on Revenue, Raises FY22 Guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $94.12 +0.94%
EPS Growth %: +1.6%
Financial Fact:
Other (income) expense, net: 972M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: +1.6%
Financial Fact:
Other (income) expense, net: 972M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q3 EPS of $1.15, $0.20 better than the analyst estimate of $0.95. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $9.63 billion.
GUIDANCE:
Abbott sees FY2022 EPS of $5.17-$5.23, versus the consensus of $5.05.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Darden Restaurants (DRI) Tops Q4 EPS by 3c, Misses on Revenue; Offers FY27 Guidance
- Qualcomm expects $40bn in non-handset revenue by fiscal 2029
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
